跳至主要内容
临床试验/JPRN-jRCT1080224691
JPRN-jRCT1080224691已完成Unknown

A Prospective, Multi-center, Single-arm Study with Congenital Heart Disease

TEIJIN LIMITED / TEIJIN PHARMA LIMITED0 个研究点目标入组 30 人开始时间: 2019年5月21日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • Inclusion Criteria:
  • - Patient with congenital heart disease requiring thoracotomy.
  • - Patient who has at least 1 site in any of the septum, the outer wall and the vascular wall to be repaired.
  • - Patient or the patient's legally acceptable representative who gives the written informed consent.

排除标准

  • Exclusion Criteria:
  • - Patient requiring emergency surgery.
  • - Patient with non-cardiac disease significantly raising surgical risk, significant non-cardiac disease with life expectancy less than 6 months, or progressive non-cardiac disease (liver failure, renal failure, cancer, etc.).
  • - Patient who has coagulation test abnormality.
  • - Patient who has familial arrhythmia.
  • - Patient who has arrhythmia observed on preoperative ECG diagnosis.
  • - Patient who is pregnant or lactating at the time of the consent.

研究者

相似试验